AVITA Medical, Inc. (RCEL) EBT (2018 - 2026)

AVITA Medical (RCEL) has reported EBT for 9 consecutive years, with -$7.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 23.05% year-over-year to -$7.6 million; the trailing twelve-month figure through Jun 2026 stood at -$42.4 million (up 17.87% YoY), and the FY2025 full-year result was -$48.6 million, up 21.39% from the prior year.
• EBT grew to -$7.6 million in Q2 2026 per RCEL's latest filing, from -$11.6 million in the prior quarter.
• Across five years, EBT topped out at -$5.6 million in Q3 2022 and bottomed at -$18.6 million in Q1 2024.
• Historically, EBT has averaged -$11.7 million across 5 years, with a median of -$11.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: EBT soared 66.44% in 2022, then plunged 102.7% in 2024.
• Over 5 years, EBT stood at -$9.8 million in 2022, then plunged by 68.09% to -$16.4 million in 2023, then climbed by 29.58% to -$11.6 million in 2024, then retreated by 0.59% to -$11.6 million in 2025, then jumped by 34.44% to -$7.6 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$7.6 million, -$11.6 million, and -$13.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.